Target intelligence / Profile preview

Ribosomal protein S3a pseudogene 52 (RPS3AP52)

Target: RPS3AP52
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein S3a pseudogene 52 (RPS3AP52) is one of many processed pseudogenes derived from the ribosomal protein S3a gene. As a pseudogene, RPS3AP52 does not encode a functional ribosomal protein and lacks protein-coding ability. Pseudogenes like RPS3AP52 may regulate gene expression post-transcriptionally, for example by acting as decoys for microRNAs or RNA-binding proteins. While altered expression or copy number variation in specific cancer types has been noted for various pseudogenes, the exact biological and clinical significance of RPS3AP52 remains undefined. There are no known drugs targeting this pseudogene, and it is not considered a therapeutic target. RPS3AP52 is used mainly for research purposes and molecular biology studies on pseudogene function and regulation.

Other names: RPS3AP52ribosomal protein S3a pseudogene 52

Biological functions

Modulation of gene expression through potential roles as a noncoding RNA, e.g., acting as a competing endogenous RNA (ceRNA) or microRNA sponge, which may impact the regulation of the parental RPS3A gene and other genes in trans

Disease associations

Other (Pseudogene alterations, including copy number changes and expression differences, have been described in various cancers, but the specific biological effect of RPS3AP52 remains unknown. There is no established direct causal disease role.)

Biomarkers

Pseudogenes, including members of this family, are sometimes explored as biomarkers for disease prognosis and diagnosis, but no specific clinical application is described for RPS3AP52

Beyond the preview

Go deeper on Ribosomal protein S3a pseudogene 52 (RPS3AP52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S3a pseudogene 52 (RPS3AP52).

Explore the full profile